Somnus Therapeutics, Inc. (Bedminster, NJ) is a private drug development company formed by Care Capital LLC. The company is developing an improved therapeutic to address the top need of insomnia patients: preventing mid-night awakenings without next-day hangovers.
View Top Employees from Somnus Therapeutics, Inc.Website | https://www.somnustherapeutics.org |
Funding | $15 million |
Employees | View employees |
Founded | 2007 |
Address | 135 Us Hwy 202-206 Ste 9, Bedminster, New Jersey 07921, US |
Phone | (908) 901-0300 |
Technologies |
JavaScript,
HTML,
PHP
+40 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Software General, Biotechnology, Drug Discovery, Software, Science and Engineering, Pharmaceuticals, Health Care, Therapeutics |
Competitors | Clearside Biomedical, Inc., InSite Vision, Inc., Omeros Corporation, Osiris Therapeutics, Receptos, a wholly-owned subsidiary of Celgene |
SIC | SIC Code 737 Companies, SIC Code 73 Companies |
NAICS | NAICS Code 511 Companies, NAICS Code 5112 Companies, NAICS Code 51 Companies |
Looking for a particular Somnus Therapeutics, Inc. employee's phone or email?
Somnus Therapeutics, Inc. is based in Bedminster, New Jersey.
The NAICS codes for Somnus Therapeutics, Inc. are [511, 5112, 51].
The SIC codes for Somnus Therapeutics, Inc. are [737, 73].